Sickle Cell Disease
Showing NaN - NaN of 46
Sickle Cell Disease, Multiple Myeloma Trial in Washington
Enrolling by invitation
- Sickle Cell Disease
- Multiple Myeloma
-
Washington, District of ColumbiaASH Research Collaborative
Mar 7, 2023
Sickle Cell Disease Trial in Adana, Mersin (NDec - oral decitabine-tetrahydrouridine, HU - Hydroxyurea, Placebo)
Recruiting
- Sickle Cell Disease
- NDec - oral decitabine-tetrahydrouridine
- +2 more
-
Oakland, California
- +39 more
Jan 24, 2023
Sickle Cell Disease Trial in United States (Hematopoietic Stem Cell Transplantation)
Completed
- Sickle Cell Disease
- Hematopoietic Stem Cell Transplantation
-
Birmingham, Alabama
- +18 more
Dec 7, 2022
Sickle Cell Disease Trial in Worldwide (Etavopivat Tablets, Placebo Tablets)
Recruiting
- Sickle Cell Disease
- Etavopivat Tablets Low dose
- +3 more
-
Birmingham, Alabama
- +77 more
Oct 11, 2022
Sickle Cell Disease Trial in Lebanon, United Kingdom, United States (Voxelotor)
Enrolling by invitation
- Sickle Cell Disease
-
Washington, District of Columbia
- +10 more
Sep 27, 2022
Sickle Cell Disease Trial in United States (Busulfan, Fludarabine, r-ATG)
Active, not recruiting
- Sickle Cell Disease
- Busulfan
- +11 more
-
Oakland, California
- +34 more
Sep 21, 2022
Sickle Cell Disease Trial in France, United Kingdom, United States (Red Blood Cell, Standard of care)
Recruiting
- Sickle Cell Disease
- Red Blood Cell
- Standard of care
-
Tuscaloosa, Alabama
- +19 more
Aug 23, 2022
Sickle Cell Disease Trial in United States (bb1111)
Recruiting
- Sickle Cell Disease
- bb1111
-
Birmingham, Alabama
- +8 more
Jul 15, 2022
SCD Curative Therapies
Not yet recruiting
- Sickle Cell Disease
- +3 more
-
Washington, District of Columbia
- +4 more
Jun 28, 2022
Near Infrared Spectroscopy in Sickle Cell Pediatric Patients
Recruiting
- Sickle Cell Disease
- Near infrared spectroscopy
-
Washington, District of ColumbiaChildren's National Medical Center
Mar 31, 2022
Sickle Cell Disease Trial in Canada, United States (Alemtuzumab intravenously, low dose total body irradiation, Sirolimus)
Recruiting
- Sickle Cell Disease
- Alemtuzumab intravenously, low dose total body irradiation, Sirolimus
-
Washington, District of Columbia
- +5 more
Mar 2, 2022
Sickle Cell Disease Trial in United States (Provider-level intervention, Patient-level intervention)
Active, not recruiting
- Sickle Cell Disease
- Provider-level intervention
- Patient-level intervention
-
Little Rock, Arkansas
- +14 more
Feb 24, 2022
Sickle Cell Disease Trial in United States (procedure, drug, radiation)
Recruiting
- Sickle Cell Disease
- Haploidentical Bone Marrow Transplantation
- +7 more
-
Birmingham, Alabama
- +31 more
Dec 30, 2021
Sickle Cell Disease Trial in United States (Arginine Hydrochloride, Normal saline)
Recruiting
- Sickle Cell Disease
- Arginine Hydrochloride
- Normal saline
-
Los Angeles, California
- +9 more
Jan 12, 2022
COVID-19 Vaccine Response in Sickle Cell Disease
Recruiting
- Sickle Cell Disease
- COVID-19
- COVID-19 Vaccine
-
Washington, District of Columbia
- +5 more
Dec 2, 2021
Sickle Cell Disease, Pain Trial in Washington (The Balance Program)
Recruiting
- Sickle Cell Disease
- Pain
- The Balance Program
-
Washington, District of ColumbiaChildren's National Hospital
Dec 13, 2021
Sickle Cell Disease, Pain Management Trial in Washington, Bethesda (Hypnosis, Control)
Completed
- Sickle Cell Disease
- Pain Management
- Hypnosis
- Control
-
Washington, District of Columbia
- +1 more
Oct 28, 2021
Sickle Cell Disease Trial in Washington (Hydroxyurea)
Completed
- Sickle Cell Disease
-
Washington, District of ColumbiaChildren's National Health System
Oct 19, 2021
Sickle Cell Disease, GVHD Trial in United States (Diphenhydramine, Acetaminophen, Methylprednisolone)
Active, not recruiting
- Sickle Cell Disease
- Graft Versus Host Disease
- Diphenhydramine
- +15 more
-
Washington, District of Columbia
- +6 more
Aug 4, 2021
Sickle Cell Disease Trial in United States (Mobile DOT)
Completed
- Sickle Cell Disease
- Mobile DOT
-
Washington, District of Columbia
- +3 more
Mar 3, 2021
Sickle Cell Disease Trial in United States (Sapropterin DiHCl)
Completed
- Sickle Cell Disease
- Sapropterin Dihydrochloride
-
Washington, District of Columbia
- +11 more
Feb 3, 2021
Sickle Cell Disease, Anemia, Anemia, Hemolytic Trial in Washington (PROMIS for Pain Management App)
Completed
- Sickle Cell Disease
- +4 more
- PROMIS for Pain Management App
-
Washington, District of ColumbiaChildren's National Hospital
Feb 22, 2021